Note: Ingredients listed on restricted chemical lists
EC/CAS
209-321-2/569-61-9
Name of the chemical
C.I. Basic Red 9
Concentration
<100
General Information
Revision date
2023-09-27
Product name
C.I. 42500; Basic Fuchsin; Basic Red 9, monohydrochloride
CAS No.
569-61-9
Emergency telephone
001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Fisher Scientific UK
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Classification of the substance or mixture GHS Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567
Physical hazards
Based on available data, the classification criteria are not met
Health hazards
Carcinogenicity Category 1B (H350)
Environmental hazards
Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
Signal word
Danger
Hazard statements
H350 - May cause cancer May form combustible dust concentrations in air
Precautionary statements
P201 - Obtain special instructions before use P308 + P313 - IF exposed or concerned: Get medical advice/attention Additional EU labelling Restricted to professional users
2.3 Other hazards
May form explosible dust-air mixture if dispersed This product does not contain any known or suspected endocrine disruptors
2.1 Classification of the substance or mixture
GHS Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Physical hazards Based on available data, the classification criteria are not met Health hazards Carcinogenicity Category 1B (H350) Environmental hazards Based on available data, the classification criteria are not met Full text of Hazard Statements: see section 16
